ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.

Abstract:

:The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.

journal_name

Blood

journal_title

Blood

authors

Yahalom J,Dabaja BS,Ricardi U,Ng A,Mikhaeel NG,Vogelius IR,Illidge T,Qi S,Wirth A,Specht L

doi

10.1182/blood.2020006028

subject

Has Abstract

pub_date

2020-05-21 00:00:00

pages

1829-1832

issue

21

eissn

0006-4971

issn

1528-0020

pii

454357

journal_volume

135

pub_type

杂志文章,实务指引

相关文献

BLOOD文献大全
  • Hormone-stimulated heme synthesis by isolated mitochondria.

    abstract::Erythropoietin (Ep), insulin, and prostaglandins E1 and A1 (PGE1, PGA1) enhanced heme synthesis by mitochondria isolated from embryonic and adult mouse liver cells. The combination of Ep with PGE1 had an antagonistic effect, while that of Ep with PGA1 gave an additive result. The capability of isolated human platelet ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Agam G,Djaldetti M

    更新日期:1978-06-01 00:00:00

  • Enrichment of natural suppressor activity in a wheat germ agglutinin positive hematopoietic progenitor-enriched fraction of monkey bone marrow.

    abstract::Natural suppressor (NS) activity, the capacity of unprimed cells to suppress immunologic responses, is present in mouse, rabbit, and human bone marrow (BM). In this study we characterize NS activity in bone marrow cells of the rhesus monkey. Greatest NS activity was found in low-density cells (1.0600 to 1.0655 g/mL) o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sugiura K,Ikehara S,Gengozian N,Inaba M,Sardiña EE,Ogata H,Seong SM,Good RA

    更新日期:1990-03-01 00:00:00

  • Hemoglobin Ohio (beta 142 Ala replaced by): a new abnormal hemoglobin with high oxygen affinity and erythrocytosis.

    abstract::Hemoglobin Ohio [beta 142 (H20) Ala replaced by Asp] was found in three members of a white family, all of whom showed erythrocytosis. The variant hemoglobin has a high oxygen affinity, a reduced Bohr effect, and diminished cooperativity. The functional abnormalities of Hb Ohio are explained by the proximity of the sub...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moo-Penn WF,Schneider RG,Shih T,Jones RT,Govindarajan S,Govindarajan PG,Patchen LC

    更新日期:1980-08-01 00:00:00

  • The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.

    abstract::Glucose is a major source of energy for living organisms, and its transport in vertebrates is a universally conserved property. Of all cell lineages, human erythrocytes express the highest level of the Glut1 glucose transporter with more than 200,000 molecules per cell. However, we recently reported that erythrocyte G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-159269

    authors: Montel-Hagen A,Blanc L,Boyer-Clavel M,Jacquet C,Vidal M,Sitbon M,Taylor N

    更新日期:2008-12-01 00:00:00

  • Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.

    abstract::The purpose of this report was to evaluate scintigraphy analysis of Southern blot hybridization as a method to quantify the breakpoint cluster region (BCR) rearrangement of Philadelphia chromosome (Ph)+ chronic myelogenous leukemia (CML). Cytogenetic and molecular studies performed simultaneously on 474 bone marrow an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verschraegen CF,Talpaz M,Hirsch-Ginsberg CF,Pherwani R,Rios MB,Stass SA,Kantarjian HM

    更新日期:1995-05-15 00:00:00

  • Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia.

    abstract::Current knowledge is inadequate to explain the different patterns of blast cell accumulation in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We compared the growth patterns of blast cell progenitors (CFU-L) in 23 patients with advanced MDS and 32 patients with de novo AML. Circulating blast progen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Aul C,Gattermann N,Schneider W

    更新日期:1992-08-01 00:00:00

  • Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression.

    abstract::CD56(high) acute myeloid leukemias (AMLs) have a poor prognosis, but it has been unclear how CD56 expression is controlled and how it relates to clinical aggressiveness. We show that CD56 expression on AML cells correlates with an abnormal expression pattern of runt-related transcription factor 1 (RUNX1) isoforms. Whe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-074203

    authors: Gattenloehner S,Chuvpilo S,Langebrake C,Reinhardt D,Müller-Hermelink HK,Serfling E,Vincent A,Marx A

    更新日期:2007-09-15 00:00:00

  • Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis.

    abstract::Lactoferrin is a major constituent of polymorphonuclear leukocyte granules and is present in mature neutrophils but not in blasts or promyelocytes. We have isolated a cDNA probe for lactoferrin and used it to study the synthesis of lactoferrin mRNA by normal and leukemic granulocyte precursors. The probe pHL-41 has be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rado TA,Wei XP,Benz EJ Jr

    更新日期:1987-10-01 00:00:00

  • Chromosome translocations involving band 7q35 or 7p15 in childhood T-cell leukemia/lymphoma.

    abstract::In a chromosome study in childhood T-cell leukemia/lymphoma, we found t(7;11)(q35;p13) in 2 patients, t(7;14) (q35;q11) in one patient, and t(7;14)(p15;q32) in 1 patient. Southern blotting and in situ chromosomal hybridization studies in one patient with the t(7;11) demonstrated that both alleles of the T-cell antigen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kaneko Y,Maseki N,Homma C,Sakurai M,Mizutani S,Takeda T,Shikano T,Fujimoto T,Yaoi K,Shimokawa T

    更新日期:1988-08-01 00:00:00

  • Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.

    abstract::Inhibition of complement-mediated granulocyte aggregation has recently been proposed as a mechanism of action of high-dose corticosteroids in shock states. Such inhibition may be effected through alteration of receptor function. Methylprednisolone inhibits binding of the synthetic chemotaxin f-methionine-leucine-pheny...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Skubitz KM,Hammerschmidt DE

    更新日期:1986-10-01 00:00:00

  • Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

    abstract::Targeting cancer stem cells is of paramount importance in successfully preventing cancer relapse. Recently, in silico screening of public gene-expression datasets identified cyclooxygenase-derived cyclopentenone prostaglandins (CyPGs) as likely agents to target malignant stem cells. We show here that Δ(12)-PGJ(3), a n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-317750

    authors: Hegde S,Kaushal N,Ravindra KC,Chiaro C,Hafer KT,Gandhi UH,Thompson JT,van den Heuvel JP,Kennett MJ,Hankey P,Paulson RF,Prabhu KS

    更新日期:2011-12-22 00:00:00

  • T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.

    abstract::T(11;18)(q21;q21) is the most common structural abnormality in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) leading to the fusion of the apoptosis inhibitor-2 (API2) gene and the MALT lymphoma-associated translocation (MALT1) gene. In 2 patients with MALT lymphoma of th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2963

    authors: Streubel B,Lamprecht A,Dierlamm J,Cerroni L,Stolte M,Ott G,Raderer M,Chott A

    更新日期:2003-03-15 00:00:00

  • Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system.

    abstract::Low-grade follicular non-Hodgkin's lymphomas are characterized by the presence of a t(14;18) chromosomal translocation that results in deregulation of the B-cell lymphoma (Bcl-2) gene. Studies in cell lines and transgenic animal models have suggested that this results in the suppression of apoptotic cell death in germ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Johnson PW,Watt SM,Betts DR,Davies D,Jordan S,Norton AJ,Lister TA

    更新日期:1993-09-15 00:00:00

  • Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.

    abstract::Classical hairy cell leukemia (cHCL) is characterized by a near 100% frequency of the BRAFV600E mutation, whereas ∼30% of variant HCLs (vHCLs) have MAP2K1 mutations. However, recurrent genetic alterations cooperating with BRAFV600E or MAP2K1 mutations in HCL, as well as those in MAP2K1 wild-type vHCL, are not well def...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-01-765107

    authors: Durham BH,Getta B,Dietrich S,Taylor J,Won H,Bogenberger JM,Scott S,Kim E,Chung YR,Chung SS,Hüllein J,Walther T,Wang L,Lu SX,Oakes CC,Tibes R,Haferlach T,Taylor BS,Tallman MS,Berger MF,Park JH,Zenz T,Abdel-Waha

    更新日期:2017-10-05 00:00:00

  • Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.

    abstract::Daratumumab targets CD38-expressing myeloma cells through a variety of immune-mediated mechanisms (complement-dependent cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and antibody-dependent cellular phagocytosis) and direct apoptosis with crosslinking. These mechanisms may also target nonplasma cells tha...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2015-12-687749

    authors: Krejcik J,Casneuf T,Nijhof IS,Verbist B,Bald J,Plesner T,Syed K,Liu K,van de Donk NW,Weiss BM,Ahmadi T,Lokhorst HM,Mutis T,Sasser AK

    更新日期:2016-07-21 00:00:00

  • One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.

    abstract::In systemic light-chain amyloidosis, λ light chains produced by clonal plasma cells cause organ damage and early death. In pursuit of novel therapy, we developed 1 pool of short interfering RNA (siRNA) targeting the constant region of λ light chains that substantially and promptly reduces λ-light-chain production and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-535187

    authors: Zhou P,Ma X,Iyer L,Chaulagain C,Comenzo RL

    更新日期:2014-05-29 00:00:00

  • Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

    abstract::We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consecutive related-donor (n = 177) and unrelated-donor (n = 106) allogeneic transplant recipients. Twenty-two of 165 related-donor recipients with stable or advanced disease at the time of transplant had hematologic relapse ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Enright H,Davies SM,DeFor T,Shu X,Weisdorf D,Miller W,Ramsay NK,Arthur D,Verfaillie C,Miller J,Kersey J,McGlave P

    更新日期:1996-07-15 00:00:00

  • P-selectin glycoprotein ligand-1 is essential for adhesion to P-selectin but not E-selectin in stably transfected hematopoietic cell lines.

    abstract::P-selectin (CD62P) is a member of the selectin family of adhesion molecules involved in the regulation of leukocyte traffic. P-selectin glycoprotein ligand-1 (PSGL-1) is a mucin-like molecule that is thought to be a primary ligand for P-selectin. The interaction of P-selectin with PSGL-1 results in leukocyte rolling a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Snapp KR,Wagers AJ,Craig R,Stoolman LM,Kansas GS

    更新日期:1997-02-01 00:00:00

  • Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.

    abstract::Several strategies can be used to manage fetal or neonatal alloimmune thrombocytopenia (FNAIT) in subsequent pregnancies. Serial fetal blood sampling (FBS) and intrauterine platelet transfusions (IUPT), as well as weekly maternal IV immunoglobulin infusion (IVIG), with or without additional corticosteroid therapy, are...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-10-739656

    authors: Winkelhorst D,Murphy MF,Greinacher A,Shehata N,Bakchoul T,Massey E,Baker J,Lieberman L,Tanael S,Hume H,Arnold DM,Baidya S,Bertrand G,Bussel J,Kjaer M,Kaplan C,Kjeldsen-Kragh J,Oepkes D,Ryan G

    更新日期:2017-03-16 00:00:00

  • A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.

    abstract::When granulocytes are stimulated under certain clinical conditions, elastase is released therefrom and digests fibrin(ogen) independently of the plasmin system, which may also be mobilized simultaneously. Thus, discrimination of these 2 systems becomes urgent for the diagnosis and treatment of the underlying diseases....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kohno I,Inuzuka K,Itoh Y,Nakahara K,Eguchi Y,Sugo T,Soe G,Sakata Y,Murayama H,Matsuda M

    更新日期:2000-03-01 00:00:00

  • Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

    abstract::Human endothelial cells release two forms of a plasminogen activator-specific inhibitor: an active form that readily binds to and inhibits plasminogen activators and an inactive or latent form that has no anti-activator activity but which can be activated by denaturation. Latent and active forms of plasminogen activat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Levin EG

    更新日期:1986-05-01 00:00:00

  • Detection of carriers of the autosomal form of chronic granulomatous disease.

    abstract::The NADPH:O2 oxidoreductase catalyzing the respiratory burst in activated phagocytes from healthy individuals is not operative in phagocytes from patients with chronic granulomatous disease (CGD). In a microscopic slide test using the dye nitroblue tetrazolium (NBT), carriers of X-linked CGD can be recognized by a mos...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verhoeven AJ,van Schaik ML,Roos D,Weening RS

    更新日期:1988-02-01 00:00:00

  • Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line.

    abstract::The biochemical signaling mechanisms involved in transducing the effects of interferon-gamma (IFN-gamma) on human leukemia-derived HL-60 cell differentiation are not completely understood. Recent studies established the existence of a sphingomyelin (SM) cycle that operates in response to the action of IFN-gamma on HL-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Visnjić D,Batinić D,Banfić H

    更新日期:1997-01-01 00:00:00

  • Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.

    abstract::In multiple myeloma (MM), both vascular endothelial (VEGF) and basic fibroblast growth factor (bFGF) promote tumor growth and survival. We have used the novel indolinone BIBF 1000 to study effects of simultaneous inhibition of VEGF, FGF and transforming growth factor-beta on MM cells and their interactions with bone m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4250

    authors: Bisping G,Kropff M,Wenning D,Dreyer B,Bessonov S,Hilberg F,Roth GJ,Munzert G,Stefanic M,Stelljes M,Scheffold C,Müller-Tidow C,Liebisch P,Lang N,Tchinda J,Serve HL,Mesters RM,Berdel WE,Kienast J

    更新日期:2006-03-01 00:00:00

  • Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits.

    abstract::Tissue type plasminogen activator (t-PA) is an effective thrombolytic agent in experimental animals. The duration of the thrombolytic effect of infused t-PA is unknown. We compared the duration of the thrombolytic effect of t-PA with streptokinase by measuring the lysis of 125I-fibrin-labeled thrombi in rabbit jugular...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Agnelli G,Buchanan MR,Fernandez F,Van Ryn J,Hirsh J

    更新日期:1985-08-01 00:00:00

  • Hypermethylation of E-cadherin in leukemia.

    abstract::E-cadherin gene is often termed a "metastasis suppressor" gene because the E-cadherin protein can suppress tumor cell invasion and metastasis. Inactivation of the E-cadherin gene occurs in undifferentiated solid tumors by both genetic and epigenetic mechanisms; however, the role of E-cadherin in hematologic malignanci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melki JR,Vincent PC,Brown RD,Clark SJ

    更新日期:2000-05-15 00:00:00

  • RUNX1 regulates corepressor interactions of PU.1.

    abstract::The transcription factor (TF) RUNX1 cooperates with lineage-specifying TFs (eg, PU.1/SPI1) to activate myeloid differentiation genes, such as macrophage and granulocyte macrophage colony-stimulating factor receptors (MCSFR and GMCSFR). Disruption of cooperative gene activation could contribute to aberrant repression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-10-312512

    authors: Hu Z,Gu X,Baraoidan K,Ibanez V,Sharma A,Kadkol S,Munker R,Ackerman S,Nucifora G,Saunthararajah Y

    更新日期:2011-06-16 00:00:00

  • Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

    abstract::The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus-driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328849

    authors: Rigaud S,Lopez-Granados E,Sibéril S,Gloire G,Lambert N,Lenoir C,Synaeve C,Stacey M,Fugger L,Stephan JL,Fischer A,Picard C,Durandy A,Chapel H,Latour S

    更新日期:2011-07-14 00:00:00

  • A cytokine receptor gene cluster in the X-Y pseudoautosomal region?

    abstract::The receptors for interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are heterodimers comprised of ligand specific alpha chains and a common beta chain. The genes encoding the IL-5 receptor alpha chain and the common beta chain reside on chromosome 3 and 22 respectively, while th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kremer E,Baker E,D'Andrea RJ,Slim R,Phillips H,Moretti PA,Lopez AF,Petit C,Vadas MA,Sutherland GR

    更新日期:1993-07-01 00:00:00

  • Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses.

    abstract::The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-075945

    authors: Hipp MM,Hilf N,Walter S,Werth D,Brauer KM,Radsak MP,Weinschenk T,Singh-Jasuja H,Brossart P

    更新日期:2008-06-15 00:00:00